The latest cancer drugs news
Browsing: Cancer Drug News
Metixene breakthrough: A new hope emerges for metastatic brain cancer patients
A new study has revealed that metixene, an antiparkinsonian drug, has shown remarkable potential as…
FDA approves encorafenib with binimetinib for metastatic non-small cell lung cancer with a BRAF V600E mutation
On October 11, 2023, the Food and Drug Administration approved encorafenib with binimetinib for adult patients with…
Bio-inspired drug boosts the efficacy of immunotherapy
A new, bio-inspired drug restores the effectiveness of immune cells in targeting cancer, a team…
Tumour-destroying soundwaves approved for liver cancer treatment by FDA
The United States Food and Drug Administration has approved the use of sound waves to…
New insights on a potentially serious side effect of the cancer drug alpelisib
New research has uncovered elevated rates of high blood sugar, or hyperglycemia, among patients with…
Better together against cancer
To give cancer treatments the greatest possible chance of success, patients are often treated with…
Uterine cancer drug gets fast-track approval
A new drug – tulmimetostat – has been given fast-track approval by the US Food and Drug…
Could a cancer drug hold the key to a HIV cure?
An existing blood cancer drug has shown promise in killing ‘silent’ HIV cells and delaying…
Scientists find evidence of unintended impacts from anti-cancer drugs
With around 90% of drugs failing to make it to market, the potential for improving…
European Commission approves reduced dosing frequency of teclistamab for multiple myeloma
The European Commission (EC) has granted the approval of a type II variation application for…